Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
TEVA
TEVA News & Events
-
Add to Watchlist
Trade TEVA
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
TEVA News
HHS Considers Restrictions on Antidepressant Use Amid Mental Health Crisis
2d ago
seekingalpha
Teva Pharmaceuticals to Present at BofA Healthcare Conference
6d ago
Newsfilter
TEVA PHARMACEUTICALS: UBS Increases Price Target from $36 to $42
May 01 2026
moomoo
Latest Developments in the Biotech Sector
Apr 30 2026
NASDAQ.COM
Teva Exceeds All Sustainability Bond Targets
Apr 30 2026
Newsfilter
Teva Acquires Emalex to Boost Growth Strategy
Apr 30 2026
Yahoo Finance
Blackstone's $400 Million Investment in Teva: A Strategic Bet
Apr 30 2026
Fool
Blackstone Commits $400 Million to Teva's Drug Development
Apr 30 2026
NASDAQ.COM
Show More News
TEVA Events
No data
TEVA Monitor News
Teva Reports Strong Q1 but Lowers Full-Year Outlook
Apr 29 2026
Teva Pharmaceutical reaches 20-day high amid strong market performance
Apr 17 2026
Teva's PONLIMSI Receives FDA Approval, Boosting Market Position
Mar 31 2026
Teva Pharmaceuticals' Transformation Amid Market Challenges
Mar 13 2026
Teva Pharmaceuticals transitions to branded drugs amid market challenges
Mar 12 2026
Teva Secures $400M Investment for Duvakitug Development
Mar 09 2026
Teva secures $400M investment for duvakitug development
Mar 05 2026
Teva Pharmaceutical Stock Declines Amid Market Weakness
Mar 03 2026
Show More Monitor News
TEVA Earnings Analysis
Teva Pharmaceutical Earnings: Q3 2025 Insights- Intellectia AI™
6 months ago
Transformative Year for Teva Pharmaceutical - Intellectia AI™
1 years ago
People Also Watch
